Lymphangiogenesis and lymphovascular invasion diminishes prognosis in esophageal cancer

Surgery (United States)

Volumn 153, Issue 4, 2013, Pages 526-534

  Schoppmann, Sebastian F ^a   Jesch, Bettina ^a   Zacherl, Johannes ^a   Riegler, Martin F ^a   Friedrich, Julia ^b   Birner, Peter ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

PODOPLANIN;

ADULT; ARTICLE; CANCER INVASION; CANCER PATIENT; CANCER PROGNOSIS; DISEASE FREE SURVIVAL; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS CANCER; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPH VESSEL ENDOTHELIUM; LYMPH VESSEL METASTASIS; LYMPHANGIOGENESIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; AGED; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84875223278     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2012.10.007     Document Type: Article

References (32)

1. F. Bruyere, and A. Noel Lymphangiogenesis: in vitro and in vivo models FASEB J 24 2010 8 21
2. J. Sleeman, A. Schmid, and W. Thiele Tumor lymphatics Semin Cancer Biol 19 2009 285 297
3. J.P. Sleeman, and W. Thiele Tumor metastasis and the lymphatic vasculature Int J Cancer 125 2009 2747 2756
4. W. Thiele, and J.P. Sleeman Tumor-induced lymphangiogenesis: a target for cancer therapy? J Biotechnol 124 2006 224 241
5. S.F. Schoppmann Lymphangiogenesis, inflammation and metastasis Anticancer Res 25 2005 4503 4511
6. S.J. Oh, M.M. Jeltsch, R. Birkenhager, J.E. McCarthy, H.A. Weich, and B. Christ VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane Dev Biol 188 1997 96 109
7. M. Skobe, T. Hawighorst, D.G. Jackson, R. Prevo, L. Janes, and P. Velasco Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis Nat Med 7 2001 192 198
8. K. Alitalo Growth factors controlling angiogenesis and lymphangiogenesis Ugeskr Laeger 164 2002 3170 3172
9. C.M. Shahbaz Sarwar, J.D. Luketich, R.J. Landreneau, and G. Abbas Esophageal cancer: an update Int J Surg 8 2010 417 422
10. M.A. Brundler, J.A. Harrison, B. de Saussure, M. de Perrot, and M.S. Pepper Lymphatic vessel density in the neoplastic progression of Barrett's oesophagus to adenocarcinoma J Clin Pathol 59 2006 191 195
11. R.S. Saad, J.L. Lindner, Y. Liu, and J.F. Silverman Lymphatic vessel density as prognostic marker in esophageal adenocarcinoma Am J Clin Pathol 131 2009 92 98
12. M. Kozlowski, W. Naumnik, J. Niklinski, R. Milewski, G. Lapuc, and J. Laudanski Lymphatic vessel invasion detected by the endothelial lymphatic marker D2-40 (podoplanin) is predictive of regional lymph node status and an independent prognostic factor in patients with resected esophageal cancer Folia Histochem Cytol 49 2011 90 97
13. L. Tong, S. Yuan, F. Feng, and H. Zhang Role of podoplanin expression in esophageal squamous cell carcinoma: a retrospective study Dis Esophagus 25 2012 72 80
14. W.Y. Chuang, C.J. Yeh, Y.C. Wu, Y.K. Chao, Y.H. Liu, and C.K. Tseng Tumor cell expression of podoplanin correlates with nodal metastasis in esophageal squamous cell carcinoma Histol Histopathol 24 2009 1021 1027
15. A.W. Griffioen Lymphangiogenesis factors: a target for therapy? Blood 113 2009 4135 4136
16. S.F. Schoppmann, G. Bayer, K. Aumayr, S. Taucher, S. Geleff, and M. Rudas Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer Ann Surg 240 2004 306 312
17. N. Weidner, J.P. Semple, W.R. Welch, and J. Folkman Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma N Engl J Med 324 1991 1 8
18. K. Alitalo, T. Tammela, and T.V. Petrova Lymphangiogenesis in development and human disease Nature 438 2005 946 953
19. V. Angeli, and G.J. Randolph Inflammation, lymphatic function, and dendritic cell migration Lymphat Res Biol 4 2006 217 228
20. S.F. Schoppmann, P. Birner, J. Stockl, R. Kalt, R. Ullrich, and C. Caucig Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis Am J Pathol 161 2002 947 956
21. A. Inoue, H. Moriya, N. Katada, S. Tanabe, N. Kobayashi, and M. Watanabe Intratumoral lymphangiogenesis of esophageal squamous cell carcinoma and relationship with regulatory factors and prognosis Pathol Int 58 2008 611 619
22. T.P. Padera, A. Kadambi, E. di Tomaso, C.M. Carreira, E.B. Brown, and Y. Boucher Lymphatic metastasis in the absence of functional intratumor lymphatics Science 296 2002 1883 1886
23. R.C. Ji Lymphatic endothelial cells, tumor lymphangiogenesis and metastasis: New insights into intratumoral and peritumoral lymphatics Cancer Metastasis Rev 25 2006 677 694
24. S.F. Schoppmann, M. Schindl, S. Breiteneder-Geleff, A. Soleima, G. Breitenecker, and B. Karner Inflammatory stromal reaction correlates with lymphatic microvessel density in early-stage cervival cancer Anticancer Res 21 2001 3419 3423
25. T.P. Padera, and R.K. Jain VEGFR3: a new target for antiangiogenesis therapy? Dev Cell 15 2008 178 179
26. A. Saaristo, T. Veikkola, T. Tammela, B. Enholm, M.J. Karkkainen, and K. Pajusola Lymphangiogenic gene therapy with minimal blood vascular side effects J Exp Med 196 2002 719 730
27. M.A. Shibata, J. Morimoto, E. Shibata, and Y. Otsuki Combination therapy with short interfering RNA vectors against VEGF-C and VEGF-A suppresses lymph node and lung metastasis in a mouse immunocompetent mammary cancer model Cancer Gene Ther 15 2008 776 786
28. S.A. Stacker, and M.G. Achen From anti-angiogenesis to anti-lymphangiogenesis: emerging trends in cancer therapy Lymphat Res Biol 6 2008 165 172
29. S.A. Stacker, R.A. Hughes, and M.G. Achen Molecular targeting of lymphatics for therapy Curr Pharm Des 10 2004 65 74
30. B. Whitehurst, M.J. Flister, J. Bagaitkar, L. Volk, C.M. Bivens, and B. Pickett Anti-VEGF-A therapy reduces lymphatic vessel density and expression of VEGFR-3 in an orthotopic breast tumor model Int J Cancer 121 2007 2181 2191
31. D. Zhang, B. Li, J. Shi, L. Zhao, X. Zhang, and C. Wang Suppression of tumor growth and metastasis by simultaneously blocking vascular endothelial growth factor (VEGF)-A and VEGF-C with a receptor-immunoglobulin fusion protein Cancer Res 70 2010 2495 2503
32. A. Salameh, F. Galvagni, M. Bardelli, F. Bussolino, and S. Oliviero Direct recruitment of CRK and GRB2 to VEGFR-3 induces proliferation, migration, and survival of endothelial cells through the activation of ERK, AKT, and JNK pathways Blood 106 2005 3423 3431